Prognosis survival time. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Bile Ducts, Intrahepatic Tumor Cells, Cultured Lymph Nodes Cells, Cultured Spleen Cell Line Bone Marrow Brain

Organisms7

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Nude Mice, Knockout Mice, SCID Mice, Inbred Strains Mice, Transgenic

Diseases70

Lung Neoplasms Adenocarcinoma Neoplasm Recurrence, Local Brain Neoplasms Liver Neoplasms Breast Neoplasms Disease Progression Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Lymphatic Metastasis Stomach Neoplasms Carcinoma, Hepatocellular Carcinoma, Squamous Cell Colorectal Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Carcinoma Glioblastoma Ovarian Neoplasms Recurrence Glioma Esophageal Neoplasms Melanoma Neoplasms Bile Duct Neoplasms Disease Models, Animal Cholangiocarcinoma Kidney Neoplasms Carcinoma, Small Cell Bone Neoplasms Supratentorial Neoplasms Skin Neoplasms Carcinoma, Renal Cell Pleural Neoplasms Mesothelioma Prostatic Neoplasms Astrocytoma Dog Diseases Colonic Neoplasms Acute Disease Multiple Myeloma Peritoneal Neoplasms Rectal Neoplasms Lymphoma Head and Neck Neoplasms Sarcoma Osteosarcoma Postoperative Complications Gallbladder Neoplasms Neovascularization, Pathologic Carcinoma, Pancreatic Ductal Neoplasms, Experimental Leukemia, Myeloid, Acute Lymphoma, Non-Hodgkin Leukemia L1210 Lymphoma, Large B-Cell, Diffuse Heart Failure Chromosome Aberrations Urinary Bladder Neoplasms Gastrointestinal Neoplasms Carcinoma, Large Cell Lymphoma, B-Cell Neuroblastoma Leukemia, Lymphocytic, Chronic, B-Cell Soft Tissue Neoplasms Ascites Biliary Tract Neoplasms Kidney Failure, Chronic Central Nervous System Neoplasms Nasopharyngeal Neoplasms

Chemicals and Drugs49

Tumor Markers, Biological Antineoplastic Agents Cisplatin Fluorouracil Doxorubicin Cyclophosphamide Deoxycytidine Antimetabolites, Antineoplastic Vincristine Paclitaxel Neoplasm Proteins Etoposide Antibodies, Monoclonal RNA, Messenger Prednisone Dacarbazine Leucovorin Tumor Suppressor Protein p53 Carboplatin Receptor, erbB-2 Ki-67 Antigen Nimustine Camptothecin Organoplatinum Compounds Antineoplastic Agents, Phytogenic Taxoids Antineoplastic Agents, Alkylating Vinblastine Methotrexate Immunosuppressive Agents Proto-Oncogene Proteins Biological Markers DNA, Neoplasm Antibodies, Monoclonal, Humanized Receptors, Estrogen Receptor, Epidermal Growth Factor Tegafur Cytarabine Oxonic Acid Antigens, Neoplasm RNA, Small Interfering Oxyquinoline Vascular Endothelial Growth Factor A Receptors, Progesterone Vindesine Tumor Suppressor Proteins Recombinant Proteins Antibiotics, Antineoplastic Epirubicin

Analytical, Diagnostic and Therapeutic Techniques and Equipment89

Prognosis Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Neoplasm Staging Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Combined Modality Therapy Immunohistochemistry Multivariate Analysis Prospective Studies Risk Factors Predictive Value of Tests Cohort Studies Drug Administration Schedule Chemotherapy, Adjuvant Risk Assessment Palliative Care Disease Models, Animal Gene Expression Profiling Remission Induction Neoplasm Transplantation Neoplasm Grading Transplantation, Homologous Reverse Transcriptase Polymerase Chain Reaction Tissue Array Analysis Registries Radiotherapy, Adjuvant Actuarial Analysis Life Tables Immunoenzyme Techniques Chi-Square Distribution Severity of Illness Index Incidence Tumor Burden Infusions, Intravenous Blotting, Western Liver Transplantation Chemoembolization, Therapeutic Skin Transplantation Radiotherapy Dosage Analysis of Variance Heart Transplantation Tomography, X-Ray Computed Oligonucleotide Array Sequence Analysis Salvage Therapy Hepatectomy Probability Clinical Trials as Topic Neoadjuvant Therapy Xenograft Model Antitumor Assays Gastrectomy Regression Analysis Karnofsky Performance Status Radiotherapy Cause of Death Transplantation, Heterologous Kidney Transplantation Neoplasms, Experimental Chemoradiotherapy Statistics, Nonparametric Biopsy Treatment Failure Case-Control Studies Immunotherapy Dose Fractionation Lymph Node Excision Randomized Controlled Trials as Topic Cranial Irradiation Polymerase Chain Reaction In Situ Hybridization, Fluorescence Models, Biological SEER Program Mitotic Index Models, Statistical Life Expectancy Corneal Transplantation Drug Therapy, Combination Patient Selection Clinical Trials, Phase III as Topic Sensitivity and Specificity Reproducibility of Results Real-Time Polymerase Chain Reaction Infusions, Intra-Arterial Random Allocation

Phenomena and Processes24

Cell Survival Graft Survival Time Factors Apoptosis Gene Expression Regulation, Neoplastic Cell Proliferation Signal Transduction Mutation Graft Rejection Dose-Response Relationship, Drug Drug Resistance, Neoplasm Chi-Square Distribution Probability Phenotype Cell Division Up-Regulation Gene Expression Genotype Longevity Chromosome Aberrations Sensitivity and Specificity Cell Movement Cell Differentiation Ploidies

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Life Tables Incidence Cause of Death SEER Program Life Expectancy

Named Groups2

Survivors Infant, Newborn

Health Care41

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Risk Factors Predictive Value of Tests Cohort Studies Age Factors Risk Assessment Palliative Care Registries Actuarial Analysis Life Tables Chi-Square Distribution Severity of Illness Index Incidence Analysis of Variance Probability Clinical Trials as Topic Regression Analysis Karnofsky Performance Status Cause of Death Sex Factors Statistics, Nonparametric Treatment Failure Case-Control Studies Randomized Controlled Trials as Topic SEER Program Models, Statistical Life Expectancy Patient Selection Clinical Trials, Phase III as Topic Sensitivity and Specificity Reproducibility of Results Random Allocation

Geographicals3

Japan China United States

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care Geographicals

Prognosis Survival Rate Cell Survival Survival Analysis Disease-Free Survival Survival Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Neoplasm Staging Graft Survival Time Factors Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Lung Neoplasms Tumor Markers, Biological Combined Modality Therapy Adenocarcinoma Immunohistochemistry Neoplasm Recurrence, Local Multivariate Analysis Antineoplastic Agents Brain Neoplasms Liver Neoplasms Breast Neoplasms Disease Progression Neoplasm Metastasis Cisplatin Carcinoma, Non-Small-Cell Lung Lymphatic Metastasis Cell Line, Tumor Prospective Studies Risk Factors Stomach Neoplasms Predictive Value of Tests Apoptosis Carcinoma, Hepatocellular Gene Expression Regulation, Neoplastic Carcinoma, Squamous Cell Fluorouracil Colorectal Neoplasms Cohort Studies Neoplasm Invasiveness Pancreatic Neoplasms Carcinoma Drug Administration Schedule Glioblastoma Age Factors Doxorubicin Cyclophosphamide Chemotherapy, Adjuvant Ovarian Neoplasms Recurrence Deoxycytidine Glioma Mice, Inbred C57BL Esophageal Neoplasms Cell Proliferation Melanoma Risk Assessment Neoplasms Mice, Inbred BALB C Antimetabolites, Antineoplastic Vincristine Palliative Care Bile Duct Neoplasms Disease Models, Animal Signal Transduction Gene Expression Profiling Remission Induction Neoplasm Transplantation Neoplasm Grading Transplantation, Homologous Cholangiocarcinoma Reverse Transcriptase Polymerase Chain Reaction Mutation Kidney Neoplasms Graft Rejection Paclitaxel Tissue Array Analysis Neoplasm Proteins Etoposide Carcinoma, Small Cell Bone Neoplasms Registries Radiotherapy, Adjuvant Antibodies, Monoclonal RNA, Messenger Dose-Response Relationship, Drug Actuarial Analysis Supratentorial Neoplasms Life Tables Mice, Nude Immunoenzyme Techniques Prednisone Drug Resistance, Neoplasm Bile Ducts, Intrahepatic Chi-Square Distribution Dacarbazine

No FAQ available that match "prognosis survival time"